Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.
Research Interests

Papers共 131 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
RNase1-driven ALK-activation is an Oncogenic Driver and Therapeutic Target in Non-Small Cell Lung Cancer
Zhengyu Zha,Chunxiao Liu,Meisi Yan, Cong Chen, Cheng Yu,Yaohui Chen, Chenhao Zhou,Lu Li, Yi-Chuan Li, Hiro Yamaguchi,Leiguang Ye, Tong Liu,Ying-Nai Wang,Heng-Huan Lee, Wen-Hao Yang,Li-Chuan Chan,Baozhen Ke,Jennifer L Hsu,Lieming Ding, Dong Ji, Peng Pan, Yiran Meng,Yue Pu,Lunxu Liu,Mien-Chie Hung
Signal transduction and targeted therapyno. 1 (2025): 124-124
Cited0Views0WOSNATUREBibtex
0
0
Discovery and Preclinical Evaluation of BPB-101: a Novel Triple Functional Bispecific Antibody Targeting GARP-TGF-β Complex/slc, Free TGF-β and PD-L1
Wenxin Xu,Jieying Xu, Pingcui Li, Deyu Xu, Hongjie Cheng, Huan Zheng,Li Zhang, Mengmeng Liu, Siyuan Ye, Mengshi Jiang, Wenqi Yu,Jiabing Wang,Lieming Ding
FRONTIERS IN IMMUNOLOGY (2024)
Cited0Views0WOSBibtex
0
0
BPI-501836: A Highly Potent Small Molecule Inhibitor Targeting KRASG12D Mutation
Xiang Yang, Yuan Lu, Renqi Xu,Xiaoqiang Kong, Yongqing Sun, Xingjie Zhu,Xiaoyun Liu,Zhengyao Zou,Haibo Chen, Yanju Liu, Jialing Sun, Han,Cheng Yang,Jing Guo,Hong Lan, Quan Zhou,Lieming Ding,Hao Wu,Jiabing Wang
Cancer Researchno. 6_Supplement (2024): 6512-6512
Cited0Views0Bibtex
0
0
Abstract CT142: Phase 1 Study of BPI-23314, a Novel BET Inhibitor and Degrader, in Advanced Myeloid Leukemia (AML)
Mingyuan Sun, Xiangyu Jin, Jing Guo, Xiaoyun Liu, Yan Xu,Hong Lan,Jiabing Wang, Jiangnan Zhen, Jing Yang,Lieming Ding,Junyuan Qi
Cancer Researchno. 7_Supplement (2024)
Cited0Views0Bibtex
0
0
Load More
Author Statistics

#Papers: 133

#Citation: 2192

H-Index: 23

G-Index: 45

Sociability: 7

Diversity: 3

Activity: 48

  • 合作者
  • 学生
  • 导师
No result temporarily, you can search similar Scholar with the same research interest
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn